Jonathan Todd Garland serves as Executive at Cytek Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Jonathan Todd Garland has executed 9 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 6, 2024 involved exercising options for 200,000 shares valued at $0.
Jonathan Todd Garland currently holds 200,000 shares of Cytek Biosciences, Inc. (CTKB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan Todd Garland has been a net neutral trader of CTKB stock. They have purchased $0 and sold $0 worth of shares.
Jonathan Todd Garland's most recent insider trade was on May 6, 2024, when they sold 200,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 2,761 |
| $N/A |
| Discretionary |
| Aug 18, 2023 | CTKB | $0 | Option Exercise | 1,951 | $N/A | Discretionary |
| Aug 18, 2023 | CTKB | $6.4K | Payment | 760 | $8.46 | Discretionary |
| Aug 18, 2023 | CTKB | $9.1K | Payment | 1,076 | $8.46 | Discretionary |
| May 18, 2023 | CTKB | $0 | Option Exercise | 1,840 | $N/A | Discretionary |
| May 18, 2023 | CTKB | $20.3K | Payment | 3,040 | $6.69 | Discretionary |
| May 18, 2023 | CTKB | $0 | Option Exercise | 7,804 | $N/A | Discretionary |
| May 18, 2023 | CTKB | $4.8K | Payment | 717 | $6.69 | Discretionary |